Physician
Canadian Heart Rhythm Society
Université de Montréal
Jason Andrade, BSc MD FRCPC FCCS FESC FHRS FEHRA is a Cardiac Electrophysiologist at Vancouver General Hospital in Canada. He is an Assistant Professor at the Université de Montréal.
Dr. Andrade is the Director of Electrophysiology at Vancouver General Hospital. He has served as co-chair of the Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines from 2017-2025, and the CCS Device Therapy Guidelines (since 2022). He has served on the executive for the Canadian Heart Rhythm Society (CHRS) as chair of the Education Committee (2013-2016) and chair of the Device Advisory Committee (2021-2025). Over the past 12 years Dr. Andrade has held multiple roles with cardiac services BC, the provincial agency responsible for delivering cardiac care in British Columbia, including the inaugural medical chair for Heart Rhythm Disease.
Dr. Andrade has authored over 325 scientific publications, predominantly in the domain of atrial fibrillation. His publications can be found in journals such as the New England Journal of Medicine, The Lancet, Circulation, the European Heart Journal, Journal of the American College of Cardiology, and the Journal of the American Medical Association. As a result of these contributions he has been recognized as a “Highly Ranked Scholar”, placing 15 worldwide for Atrial fibrillation and 27 for Catheter Ablation research.
Dr. Andrade has received numerous awards including the Canadian Institute of Health Research/CCS Mid-Career Lecturer Award in Cardiovascular Sciences, the VMDAS Scientific Achievement award, the CHRS George Klein Award, the Clinical Faculty Award for Excellence in Research, the Donald M Whitelaw Award, the Alumni Achievement Award (Ottawa), the Robert E. Beamish Award, the Michael Smith Foundation for Health Research Clinical Investigator Scholar Award, the CCS Bayer Award, the Joseph J. Diamond Memorial Prize for Research, the Peter J Armanious Award , and was recognized by the Vancouver Whitecaps as Frontline Hero of the Match.
Disclosure information not submitted.
165 - CHRS / CSCS WORKSHOP ON NON-PHARMACOLOGICAL APPROACHES TO HYPERTROPHIC CARDIOMYOPATHY
Thursday, October 23, 2025
4:30pm - 5:30pm ET
201 - CHRS SPOTLIGHT: CATHETER ABLATION AS FIRST LINE THERAPY IN 2025
Friday, October 24, 2025
8:30am - 9:30am ET
256 - MY WORST ARRHYTHMIA NIGHTMARE WORKSHOP AT CCC 2025
Friday, October 24, 2025
3:15pm - 4:15pm ET
266 - CCS/CHRS GUIDELINE FOR THE MANAGEMENT OF CARDIAC IMPLANTABLE ELECTRONIC DEVICES
Friday, October 24, 2025
4:30pm - 5:30pm ET
432 - CCS GUIDELINES RAPID REVIEW SESSION 2
Sunday, October 26, 2025
11:15am - 12:15pm ET